- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.59 Å
- Oligo State
- homo-dimer
- Ligands
- 4 x JDG: 2-cyclohexyl-7-methoxy-N-[1-(propan-2-yl)piperidin-4-yl]-8-[3-(pyrrolidin-1-yl)propoxy]-3H-1,4-benzodiazepin-5-amine(Non-covalent)
- 8 x ZN: ZINC ION(Non-covalent)
ZN.3: 7 residues within 4Å:- Chain A: C.57, C.63, C.100, C.106, C.110
- Ligands: ZN.4, ZN.5
4 PLIP interactions:4 interactions with chain A- Metal complexes: A:C.63, A:C.100, A:C.106, A:C.110
ZN.4: 6 residues within 4Å:- Chain A: C.57, C.70, C.100, C.104
- Ligands: ZN.3, ZN.5
4 PLIP interactions:4 interactions with chain A- Metal complexes: A:C.57, A:C.70, A:C.100, A:C.104
ZN.5: 6 residues within 4Å:- Chain A: C.57, C.59, C.63, C.68
- Ligands: ZN.3, ZN.4
4 PLIP interactions:4 interactions with chain A- Metal complexes: A:C.57, A:C.59, A:C.63, A:C.68
ZN.6: 4 residues within 4Å:- Chain A: C.198, C.251, C.253, C.258
4 PLIP interactions:4 interactions with chain A- Metal complexes: A:C.198, A:C.251, A:C.253, A:C.258
ZN.18: 6 residues within 4Å:- Chain B: C.57, C.59, C.63, C.68
- Ligands: ZN.19, ZN.20
4 PLIP interactions:4 interactions with chain B- Metal complexes: B:C.57, B:C.59, B:C.63, B:C.68
ZN.19: 7 residues within 4Å:- Chain B: C.57, C.63, C.100, C.106, C.110
- Ligands: ZN.18, ZN.20
4 PLIP interactions:4 interactions with chain B- Metal complexes: B:C.63, B:C.100, B:C.106, B:C.110
ZN.20: 6 residues within 4Å:- Chain B: C.57, C.70, C.100, C.104
- Ligands: ZN.18, ZN.19
4 PLIP interactions:4 interactions with chain B- Metal complexes: B:C.57, B:C.70, B:C.100, B:C.104
ZN.21: 4 residues within 4Å:- Chain B: C.198, C.251, C.253, C.258
4 PLIP interactions:4 interactions with chain B- Metal complexes: B:C.198, B:C.251, B:C.253, B:C.258
- 2 x SAH: S-ADENOSYL-L-HOMOCYSTEINE(Non-covalent)
SAH.7: 18 residues within 4Å:- Chain A: M.131, G.132, W.133, S.167, Y.168, R.192, F.193, I.194, N.195, H.196, Y.237, F.241, F.249, S.250, C.251, R.252, C.253
- Ligands: EDO.9
10 PLIP interactions:10 interactions with chain A- Hydrogen bonds: A:W.133, A:W.133, A:S.167, A:Y.168, A:Y.168, A:N.195, A:H.196, A:H.196, A:R.252
- Water bridges: A:S.167
SAH.22: 16 residues within 4Å:- Chain B: M.131, G.132, W.133, S.167, Y.168, R.192, F.193, I.194, N.195, H.196, Y.237, F.241, F.249, S.250, C.251, R.252
12 PLIP interactions:12 interactions with chain B- Hydrogen bonds: B:W.133, B:W.133, B:S.167, B:Y.168, B:N.195, B:H.196, B:H.196, B:Y.237, B:R.252, B:C.253
- Water bridges: B:R.127, B:S.167
- 14 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.8: 6 residues within 4Å:- Chain A: R.127, T.128, R.129, D.130, M.131, G.132
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:T.128, A:G.132
EDO.9: 3 residues within 4Å:- Chain A: F.249, R.252
- Ligands: SAH.7
No protein-ligand interaction detected (PLIP)EDO.10: 5 residues within 4Å:- Chain A: C.59, I.60, D.61, S.65, N.67
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:I.60, A:S.65
EDO.11: 6 residues within 4Å:- Chain A: N.39, I.47, L.154, H.211, F.216, R.218
6 PLIP interactions:6 interactions with chain A- Hydrogen bonds: A:N.39, A:F.216, A:R.218
- Water bridges: A:N.39, A:R.218, A:R.218
EDO.12: 2 residues within 4Å:- Chain A: R.7, P.17
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:R.7, A:R.7
EDO.13: 3 residues within 4Å:- Chain A: G.12
- Chain B: W.107, N.109
1 PLIP interactions:1 interactions with chain A- Water bridges: A:D.8
EDO.14: 6 residues within 4Å:- Chain A: R.49
- Chain B: N.39, V.41, I.47, R.49
- Ligands: EDO.23
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:R.49
- Water bridges: B:V.41
EDO.15: 5 residues within 4Å:- Chain A: P.30, S.31, Y.33, K.34, Y.35
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:S.31, A:Y.35
- Water bridges: A:R.11
EDO.23: 7 residues within 4Å:- Chain B: N.39, I.47, L.154, H.211, F.216, R.218
- Ligands: EDO.14
6 PLIP interactions:6 interactions with chain B- Hydrogen bonds: B:N.39, B:F.216
- Water bridges: B:N.39, B:R.218, B:R.218, B:R.218
EDO.24: 5 residues within 4Å:- Chain B: G.246, K.247, L.248, F.249, S.250
No protein-ligand interaction detected (PLIP)EDO.25: 5 residues within 4Å:- Chain B: P.30, S.31, Y.33, K.34, Y.35
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:S.31, B:Y.35
- Water bridges: B:K.34
EDO.26: 5 residues within 4Å:- Chain B: R.120, A.121, Q.139, P.142, T.145
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:Q.139, B:T.145
- Water bridges: B:R.84
EDO.27: 7 residues within 4Å:- Chain B: D.25, R.127, T.128, R.129, D.130, M.131, G.132
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:D.25, B:G.132
- Water bridges: B:D.130, B:M.131
EDO.28: 5 residues within 4Å:- Chain B: F.170, F.235, D.236, Y.237
- Ligands: JDG.17
1 PLIP interactions:1 interactions with chain B- Water bridges: B:D.171
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Milite, C. et al., Discovery of a Novel Chemotype of Histone Lysine Methyltransferase EHMT1/2 (GLP/G9a) Inhibitors: Rational Design, Synthesis, Biological Evaluation, and Co-crystal Structure. J. Med. Chem. (2019)
- Release Date
- 2019-02-27
- Peptides
- Histone-lysine N-methyltransferase EHMT1: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.59 Å
- Oligo State
- homo-dimer
- Ligands
- 4 x JDG: 2-cyclohexyl-7-methoxy-N-[1-(propan-2-yl)piperidin-4-yl]-8-[3-(pyrrolidin-1-yl)propoxy]-3H-1,4-benzodiazepin-5-amine(Non-covalent)
- 8 x ZN: ZINC ION(Non-covalent)
- 2 x SAH: S-ADENOSYL-L-HOMOCYSTEINE(Non-covalent)
- 14 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Milite, C. et al., Discovery of a Novel Chemotype of Histone Lysine Methyltransferase EHMT1/2 (GLP/G9a) Inhibitors: Rational Design, Synthesis, Biological Evaluation, and Co-crystal Structure. J. Med. Chem. (2019)
- Release Date
- 2019-02-27
- Peptides
- Histone-lysine N-methyltransferase EHMT1: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B